Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancer
Objective: c-Met is expressed in human ovarian cancer tissues, and its phosphorylation activates signaling cascades that might affect the behavior of cancer cells. In this study, we evaluated the association of c-Met and phosphorylated c-Met (phospho-c-Met) expressions with the clinical outcomes of...
Saved in:
Main Authors: | Ling Lim (Author), Chao-Chih Wu (Author), Yun-Ting Hsu (Author), Fang-Ju Sun (Author), Chih-Long Chang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antitumor effects of BMS-777607 on ovarian cancer cells with constitutively activated c-MET
by: Chao-Chih Wu, et al.
Published: (2019) -
Expression of c-MET in Invasive Meningioma
by: Sumi Yun, et al.
Published: (2015) -
Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody
by: Huang L, et al.
Published: (2020) -
New Preclinical Development of a c-Met Inhibitor and Its Combined Anti-Tumor Effect in c-Met-Amplified NSCLC
by: Nam Ah Kim, et al.
Published: (2020) -
Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations
by: Pengyun Li, et al.
Published: (2023)